Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,129 | -199,581 | -144,517 | -95,115 | -47,951 |
| Depreciation Amortization | 8,176 | 18,114 | 9,945 | 7,110 | 2,669 |
| Accounts receivable | -4,587 | -35,639 | -30,563 | -22,936 | -12,043 |
| Accounts payable and accrued liabilities | -3,952 | 28,766 | 18,576 | 8,567 | -1,267 |
| Other Working Capital | -11,359 | -23,956 | -22,403 | -20,264 | -15,791 |
| Other Operating Activity | 19,029 | 61,866 | 45,656 | 37,529 | 25,744 |
| Operating Cash Flow | $-41,822 | $-150,430 | $-123,306 | $-85,109 | $-48,639 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,240 | -9,958 | -7,911 | -7,118 | -4,939 |
| Purchase Of Investment | -15,834 | -165,454 | -97,268 | N/A | N/A |
| Sale Of Investment | 50,557 | N/A | 0 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -7,835 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -7,835 | 0 | 0 | 0 |
| Investing Cash Flow | $33,483 | $-183,247 | $-105,179 | $-7,118 | $-4,939 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 308,349 | 308,349 | N/A | N/A |
| Common Stock Issued | -1,422 | 1,445 | -222 | -593 | 375 |
| Other Financing Activity | 0 | -34,995 | -33,758 | -635 | -747 |
| Financing Cash Flow | $-1,422 | $274,799 | $274,369 | $-1,228 | $-372 |
| Beginning Cash Position | 143,940 | 202,818 | 202,818 | 202,818 | 202,818 |
| End Cash Position | 134,179 | 143,940 | 248,702 | 109,363 | 148,868 |
| Net Cash Flow | $-9,761 | $-58,878 | $45,884 | $-93,455 | $-53,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,822 | -150,430 | -123,306 | -85,109 | -48,639 |
| Capital Expenditure | -1,240 | -9,958 | -7,911 | -7,118 | -4,939 |
| Free Cash Flow | -43,062 | -160,388 | -131,217 | -92,227 | -53,578 |